Get the Stockscreener App
23.52
0.04%
0.01
After Hours:
23.49
-0.025
-0.11%
Tourmaline Bio Inc stock is traded at $23.52, with a volume of 153.89K.
It is up +0.04% in the last 24 hours and up +18.94% over the past month.
Tourmaline Bio Inc is a late-stage clinical biotechnology company driven by its mission to develop transformative medicines that dramatically improve the lives of patients with life-altering immune diseases. Its initial product candidate is TOUR006, a fully human monoclonal antibody that selectively binds to interleukin-6 (IL-6), a key proinflammatory cytokine involved in the pathogenesis of many autoimmune and inflammatory disorders. The anti-IL-6 and anti-IL-6 receptor (IL-6R) antibody class (IL-6 class) has over two decades of clinical and commercial experience treating over a million patients with a variety of autoimmune and inflammatory diseases.
See More
Previous Close:
$23.50
Open:
$23.46
24h Volume:
153.89K
Relative Volume:
0.73
Market Cap:
$604.15M
Revenue:
-
Net Income/Loss:
$11.77M
P/E Ratio:
40.65
EPS:
0.5785
Net Cash Flow:
$-19.23M
1W Performance:
+4.70%
1M Performance:
+18.94%
6M Performance:
+83.85%
1Y Performance:
+40.81%
1-Day Range:
$23.23
$24.56
1-Week Range:
$22.24
$24.56
52-Week Range:
$11.56
$29.79
Tourmaline Bio Inc Stock (TRML) Company Profile
Name
Tourmaline Bio Inc
Sector
Industry
Phone
646-481-9832
Address
27 WEST 24TH STREET, NEW YORK
Compare TRML with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TRML
Tourmaline Bio Inc
|
23.52 | 603.90M | 0 | 11.77M | -19.23M | 0.5785 |
|
VRTX
Vertex Pharmaceuticals Inc
|
389.08 | 99.27B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
586.96 | 62.28B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.18 | 59.14B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
707.96 | 43.34B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
300.14 | 36.72B | 3.81B | -644.79M | -669.77M | -6.24 |
Tourmaline Bio Inc Stock (TRML) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-23-25 | Initiated | Chardan Capital Markets | Buy |
| Mar-06-25 | Initiated | Wedbush | Outperform |
| Dec-06-24 | Initiated | BMO Capital Markets | Outperform |
| Nov-11-24 | Reiterated | H.C. Wainwright | Buy |
| Dec-15-23 | Initiated | Jefferies | Buy |
| Dec-04-23 | Resumed | H.C. Wainwright | Buy |
| Nov-17-23 | Initiated | Truist | Buy |
| Oct-31-23 | Initiated | Guggenheim | Buy |
| Oct-25-23 | Initiated | Piper Sandler | Overweight |
| Oct-20-22 | Initiated | H.C. Wainwright | Buy |
| Jul-05-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
View All
Tourmaline Bio Inc Stock (TRML) Latest News
Real time breakdown of Tourmaline Bio Inc. stock performance2025 Major Catalysts & Daily Stock Trend Reports - Newser
Is Tourmaline Bio Inc. stock ready for a breakoutEarnings Summary Report & Capital Efficient Trading Techniques - Newser
How to track smart money flows in Tourmaline Bio Inc.Market Performance Summary & AI Powered Market Trend Analysis - Newser
Exit strategy if you’re trapped in Tourmaline Bio Inc.Analyst Downgrade & Community Verified Watchlist Alerts - Newser
Will a bounce in Tourmaline Bio Inc. offer an exitRisk Management & Weekly High Conviction Ideas - Newser
Reversal indicators forming on Tourmaline Bio Inc. stock2025 Technical Overview & Low Volatility Stock Recommendations - Newser
Tourmaline Bio To Present New Phase 2 TRANQUILITY Data At ESC Congress 2025 - RTTNews
Is Tourmaline Bio Inc. forming a reversal patternWeekly Stock Summary & Capital Efficient Trading Techniques - Newser
Is Tourmaline Bio Inc. a candidate for recovery playJuly 2025 PostEarnings & High Return Trade Opportunity Guides - Newser
Multi factor analysis applied to Tourmaline Bio Inc.Weekly Profit Summary & Low Risk High Win Rate Picks - Newser
Aug Sectors: Is Tourmaline Bio Inc. stock a smart retirement pick2025 Volatility Report & Daily Entry Point Trade Alerts - theviewers.co.kr
Tourmaline Bio Inc. stock chart pattern explainedEarnings Miss & High Conviction Buy Zone Alerts - Newser
Is Tourmaline Bio Inc. trending in predictive chart modelsMarket Weekly Review & Weekly Stock Performance Updates - Newser
How to use a screener to detect Tourmaline Bio Inc. breakoutsJuly 2025 Market Mood & AI Based Buy/Sell Signal Reports - Newser
Multi asset correlation models including Tourmaline Bio Inc.Trade Exit Summary & Technical Confirmation Trade Alerts - Newser
Will Tourmaline Bio Inc. continue its uptrendWeekly Stock Analysis & Weekly Top Gainers Trade List - Newser
Wyckoff Accumulation Phase Possible in Tourmaline Bio Inc.July 2025 Fed Impact & Community Verified Trade Alerts - newsyoung.net
Price Channel Expanding on Tourmaline Bio Inc.’s Chart2025 Volatility Report & Real-Time Volume Analysis Alerts - beatles.ru
AI Trend Models Suggest Bounce for Tourmaline Bio Inc.Trade Ideas & Fast Entry High Yield Tips - newsyoung.net
Tourmaline Bio Inc. Stock Approaches Key Moving AverageTrade Analysis Summary & Step-by-Step Swing Trade Plans - newsyoung.net
Is Tourmaline Bio Inc. stock entering bullish territory2025 Top Gainers & Fast Entry Momentum Alerts - Newser
Analyzing Zevra Therapeutics (NASDAQ:ZVRA) and Tourmaline Bio (NASDAQ:TRML) - Defense World
Detecting support and resistance levels for Tourmaline Bio Inc.July 2025 Pullbacks & High Conviction Buy Zone Alerts - Newser
How high can Tourmaline Bio Inc. stock goRate Hike & Daily Stock Trend Reports - Newser
Tourmaline Bio Inc. Company Revenue and Profit Trends: A Deep DivePortfolio Gains Report & Long Hold Capital Preservation Plans - Newser
Detecting support and resistance levels for Tourmaline Bio IncJuly 2025 Gainers & Technical Entry and Exit Tips - Newser
Analysts Set Expectations for Tourmaline Bio FY2025 Earnings - Defense World
Lifesci Capital Expects Higher Earnings for Tourmaline Bio - Defense World
Tourmaline Bio Q3 EPS Forecast Raised by Leerink Partnrs - Defense World
What is Wedbush’s Forecast for Tourmaline Bio Q3 Earnings? - Defense World
Analyzing Tourmaline Bio Inc. with risk reward ratio chartsCPI Data & Weekly Breakout Stock Alerts - Newser
Comparing Tourmaline Bio Inc. in custom built stock radarsWeekly Trade Report & Precise Swing Trade Entry Alerts - Newser
Tourmaline Bio Inc. Recovery Hinges on Volume BreakoutMarket Activity Report & Safe Entry Point Alerts - news-j.co.kr
Tourmaline Bio’s (TRML) Buy Rating Reiterated at Guggenheim - Defense World
What to do if you’re stuck in Tourmaline Bio Inc.Dollar Strength & Real-Time Market Trend Scan - Newser
Can momentum traders help lift Tourmaline Bio Inc.July 2025 Action & Weekly Top Stock Performers List - Newser
Analyzing Tourmaline Bio Inc. with multi timeframe charts2025 Growth vs Value & AI Enhanced Trading Signals - Newser
Short Term Trend Reversal in Tourmaline Bio Inc. Possible2025 Analyst Calls & Momentum Based Trading Ideas - beatles.ru
Tourmaline Bio Inc Stock (TRML) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.98%
8.06%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):